These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 8573016)

  • 1. Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Cooperative Group.
    Kivlin JD; Biglan AW; Gordon RA; Dobson V; Hardy RA; Palmer EA; Tung B; Gilbert W; Spencer R; Cheng KP; Buckley E
    Arch Ophthalmol; 1996 Feb; 114(2):150-4. PubMed ID: 8573016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involution of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
    Repka MX; Palmer EA; Tung B
    Arch Ophthalmol; 2000 May; 118(5):645-9. PubMed ID: 10815156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.
    Early Treatment For Retinopathy Of Prematurity Cooperative Group
    Arch Ophthalmol; 2003 Dec; 121(12):1684-94. PubMed ID: 14662586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity.
    Palmer EA; Hardy RJ; Dobson V; Phelps DL; Quinn GE; Summers CG; Krom CP; Tung B;
    Arch Ophthalmol; 2005 Mar; 123(3):311-8. PubMed ID: 15767472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity.
    Topilow HW; Ackerman AL
    Arch Ophthalmol; 1996 Sep; 114(9):1160. PubMed ID: 8790116
    [No Abstract]   [Full Text] [Related]  

  • 6. Laser photocoagulation (810 nm diode) for threshold retinopathy of prematurity: a prospective randomized pilot study of treatment to ridge and avascular retina versus avascular retina alone.
    Uparkar M; Sen P; Rawal A; Agarwal S; Khan B; Gopal L
    Int Ophthalmol; 2011 Feb; 31(1):3-8. PubMed ID: 21194006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter trial of cryotherapy for retinopathy of prematurity: natural history ROP: ocular outcome at 5(1/2) years in premature infants with birth weights less than 1251 g.
    Cryotherapy for Retinopathy of Prematurity Cooperative Group
    Arch Ophthalmol; 2002 May; 120(5):595-9. PubMed ID: 12003608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of retinopathy of prematurity in fellow eyes in the cryotherapy for retinopathy of prematurity study. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.
    Quinn GE; Dobson V; Biglan A; Evans J; Plotsky D; Hardy RJ
    Arch Ophthalmol; 1995 Apr; 113(4):469-73. PubMed ID: 7710397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The outcome of retinopathy of prematurity: screening for retinopathy of prematurity using an outcome predictive program.
    Onofrey CB; Feuer WJ; Flynn JT
    Ophthalmology; 2001 Jan; 108(1):27-34; discussion 34-5. PubMed ID: 11150259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
    Arch Ophthalmol; 1990 Feb; 108(2):195-204. PubMed ID: 2405827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies.
    Reynolds JD; Dobson V; Quinn GE; Fielder AR; Palmer EA; Saunders RA; Hardy RJ; Phelps DL; Baker JD; Trese MT; Schaffer D; Tung B;
    Arch Ophthalmol; 2002 Nov; 120(11):1470-6. PubMed ID: 12427059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results].
    Autrata R; Senková K; Holousová M; Krejcírová I; Dolezel Z; Borek I
    Cesk Slov Oftalmol; 2012 Feb; 68(1):29-36. PubMed ID: 22679695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zone I retinopathy of prematurity.
    Katz X; Kychenthal A; Dorta P
    J AAPOS; 2000 Dec; 4(6):373-6. PubMed ID: 11124674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual fields measured with double-arc perimetry in eyes with threshold retinopathy of prematurity from the cryotherapy for retinopathy of prematurity trial. The CRYO-Retinopathy of Prematurity Cooperative Group.
    Quinn GE; Dobson V; Hardy RJ; Tung B; Phelps DL; Palmer EA
    Ophthalmology; 1996 Sep; 103(9):1432-7. PubMed ID: 8841302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk analysis of prethreshold retinopathy of prematurity.
    Hardy RJ; Palmer EA; Dobson V; Summers CG; Phelps DL; Quinn GE; Good WV; Tung B;
    Arch Ophthalmol; 2003 Dec; 121(12):1697-701. PubMed ID: 14662587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial variation in retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.
    Saunders RA; Donahue ML; Christmann LM; Pakalnis AV; Tung B; Hardy RJ; Phelps DL
    Arch Ophthalmol; 1997 May; 115(5):604-8. PubMed ID: 9152127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rate of retinal vessel dilation in severe retinopathy of prematurity requiring treatment.
    Grunwald L; Mills MD; Johnson KS; Karp KA; Quinn GE; Ying GS; Grunwald JE
    Am J Ophthalmol; 2009 Jun; 147(6):1086-91, 1091.e1-2. PubMed ID: 19286152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome-based management of retinopathy of prematurity. Multicenter Trial of Cryotherapy for Retinopathy of prematurity Cooperative Group.
    Hardy RJ; Palmer EA; Schaffer DB; Phelps DL; Davis BR; Cooper CJ
    J AAPOS; 1997 Mar; 1(1):46-54. PubMed ID: 10530985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial retinal detachment at 3 months after threshold retinopathy of prematurity. Long-term structural and functional outcome. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Cooperative Group.
    Gilbert WS; Quinn GE; Dobson V; Reynolds J; Hardy RJ; Palmer EA
    Arch Ophthalmol; 1996 Sep; 114(9):1085-91. PubMed ID: 8790093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of visual function in eyes with mild to moderate posterior pole residua of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
    Reynolds J; Dobson V; Quinn GE; Gilbert WS; Tung B; Robertson J; Flynn JT
    Arch Ophthalmol; 1993 Aug; 111(8):1050-6. PubMed ID: 8352687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.